Inogen | INGN - Loan Capital


Inogen reported $0 in Loan Capital for its fiscal quarter ending in June of 2022.





Loan Capital Change Date
Abbott USD 29.64B 19.74B Mar/2026
Accuray USD 127.32M 3.53M Sep/2025
AngioDynamics USD 5.6M 100K Sep/2025
Artivion USD 217.81M 2.94M Dec/2025
AtriCure USD 61M 865K Mar/2026
Baxter International USD 8.62B 852M Mar/2026
Becton, Dickinson and Co. USD 16.92B 705M Dec/2025
Boston Scientific USD 11.01B 19M Dec/2025
Chart Industries USD 3.57B 84.3M Dec/2025
Cooper Companies USD 1.88B 578.5M Dec/2025
Dexcom USD 1.3B 54.4M Mar/2026
Edwards Lifesciences USD 600M 1.7M Mar/2026
Globus Medical USD 436K 9K Dec/2025
Inogen USD 0 0 Jun/2022
Insulet USD 930.8M 4.1M Dec/2025
Masimo USD 518M 41.1M Dec/2025
Medtronic USD 27.88B 255M Dec/2025
Orthofix International USD 221.33M 46.88M Mar/2026
Philips EUR 6.93B 303M Dec/2025
ResMed USD 404.17M 245K Mar/2026
Steris USD 1.9B 1.1M Dec/2025
Stryker USD 14.22B 635M Mar/2026
Tandem Diabetes Care USD 310.04M 446K Dec/2025
Teleflex USD 2.54B 30.06M Dec/2025
X T L Biopharmaceuticals USD 0 0 Dec/2024
Zimmer Biomet Holdings USD 6.3B 636.9M Mar/2026